Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arvind V Ramesh"'
Autor:
Michael Ulm, Arvind V Ramesh, Keely M McNamara, Suriyan Ponnusamy, Hironobu Sasano, Ramesh Narayanan
Publikováno v:
Endocrine Connections, Vol 8, Iss 2, Pp R10-R26 (2019)
Hormonal cancers affect over 400,000 men and women and contribute collectively to over 100,000 deaths in the United States alone. Thanks to advances in the understanding of these cancers at the molecular level and to the discovery of several disease-
Externí odkaz:
https://doaj.org/article/7d0aac4c1e994aafb0e02f6435b03e06
Autor:
Emily Wang, Antonio Dono, Yoshua Esquenazi, Arvind V. Ramesh, Leomar Y. Ballester, Nitin Tandon, Victor Lopez-Rivera
Publikováno v:
Journal of Neuro-Oncology. 148:389-397
Glioblastomas (GBMs) usually occur as a solitary lesion; however, about 0.5–35% present with multiple lesions (M-GBM). The genetic landscape of GBMs have been thoroughly investigated; nevertheless, differences between M-GBM and single-foci GBM (S-G
Autor:
Antonio, Dono, Arvind V, Ramesh, Emily, Wang, Mauli, Shah, Nitin, Tandon, Leomar Y, Ballester, Yoshua, Esquenazi
Publikováno v:
Neuro-oncology Advances
Background Recent studies have identified that glioblastoma IDH-wildtype (GBM IDH-WT) might be comprised of molecular subgroups with distinct prognoses. Therefore, we investigated the correlation between genetic alterations and survival in 282 GBM ID
Autor:
Leomar Y. Ballester, Arvind V. Ramesh, Antonio Dono, Yoshua Esquenazi, Emily Wang, Nitin Tandon, Mauli Shah
Publikováno v:
Neuro-Oncology Advances. 3
Background Recent studies have identified that glioblastoma IDH-wildtype (GBM IDH-WT) might be comprised of molecular subgroups with distinct prognoses. Therefore, we investigated the correlation between genetic alterations and survival in 282 GBM ID
Autor:
Suriyan Ponnusamy, Michael A. Ulm, Hironobu Sasano, Ramesh Narayanan, Keely May McNamara, Arvind V Ramesh
Publikováno v:
Endocrine Connections, Vol 8, Iss 2, Pp R10-R26 (2019)
Endocrine Connections
Endocrine Connections
Hormonal cancers affect over 400,000 men and women and contribute collectively to over 100,000 deaths in the United States alone. Thanks to advances in the understanding of these cancers at the molecular level and to the discovery of several disease-